K2M Group Holdings, Inc. (NASDAQ:KTWO) CFO Gregory S. Cole sold 42,947 shares of the company’s stock in a transaction dated Friday, June 16th. The stock was sold at an average price of $22.80, for a total value of $979,191.60. Following the sale, the chief financial officer now owns 87,425 shares of the company’s stock, valued at approximately $1,993,290. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Shares of K2M Group Holdings, Inc. (NASDAQ:KTWO) opened at 23.42 on Tuesday. The company’s market cap is $996.66 million. K2M Group Holdings, Inc. has a 52 week low of $14.49 and a 52 week high of $23.92. The company’s 50-day moving average price is $22.44 and its 200 day moving average price is $21.06.

K2M Group Holdings (NASDAQ:KTWO) last announced its quarterly earnings results on Tuesday, May 2nd. The medical device company reported ($0.26) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.24) by $0.02. The business had revenue of $61.89 million for the quarter, compared to analyst estimates of $60.10 million. K2M Group Holdings had a negative return on equity of 16.02% and a negative net margin of 17.48%. On average, equities analysts forecast that K2M Group Holdings, Inc. will post ($0.80) EPS for the current fiscal year.

Insider Buying and Selling by Quarter for K2M Group Holdings (NASDAQ:KTWO)

ILLEGAL ACTIVITY NOTICE: “Gregory S. Cole Sells 42,947 Shares of K2M Group Holdings, Inc. (KTWO) Stock” was reported by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US & international copyright legislation. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2017/06/20/gregory-s-cole-sells-42947-shares-of-k2m-group-holdings-inc-ktwo-stock.html.

Several analysts have recently issued reports on KTWO shares. Needham & Company LLC reiterated a “buy” rating and set a $29.00 price target on shares of K2M Group Holdings in a research note on Tuesday, March 7th. Zacks Investment Research upgraded K2M Group Holdings from a “sell” rating to a “hold” rating in a research note on Thursday, March 23rd. JMP Securities reiterated an “outperform” rating and set a $27.00 price target on shares of K2M Group Holdings in a research note on Wednesday, April 12th. TheStreet upgraded K2M Group Holdings from a “d+” rating to a “c” rating in a research note on Monday, May 8th. Finally, Oppenheimer Holdings, Inc. set a $26.00 price target on K2M Group Holdings and gave the stock a “buy” rating in a research note on Wednesday, May 3rd. One investment analyst has rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $25.13.

A number of institutional investors have recently made changes to their positions in KTWO. Legal & General Group Plc increased its position in shares of K2M Group Holdings by 9.1% in the first quarter. Legal & General Group Plc now owns 6,763 shares of the medical device company’s stock worth $138,000 after buying an additional 564 shares during the period. Simplex Trading LLC acquired a new position in shares of K2M Group Holdings during the first quarter worth $187,000. Teton Advisors Inc. acquired a new position in shares of K2M Group Holdings during the fourth quarter worth $200,000. Parkwood LLC acquired a new position in shares of K2M Group Holdings during the first quarter worth $223,000. Finally, Paradigm Capital Management Inc. NY acquired a new position in shares of K2M Group Holdings during the first quarter worth $226,000. 98.82% of the stock is currently owned by hedge funds and other institutional investors.

About K2M Group Holdings

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.